Clinical Trial Update: Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years [Phase 3]

View source ↗

Summary

Phase 3 trial updating immunogenicity and safety of Kinrix+ (MMR) with and without Varicella in healthy children 4-6 years; completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Tetanus

Drugs mentioned

• Kinrix+
• Measles, Mumps, Rubella vaccine (Measles, Mumps, Rubella vaccine)
• Varicella vaccine (varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tetanus, Acellular Pertussis | Phase 3 | Status: COMPLETED | Results posted: 2011-02-10